Exploration of Plasma Biomarkers of Neurodegeneration in Obstructive Sleep Apnea—Related Mild Cognitive Impairment
Clinical Otolaryngology · 2026
DOI: 10.1111/coa.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Otolaryngology, 2026. Verfasst von Lina Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Sleep Apnea, Obstructive, Amyloid beta-Peptides, Neurofilament Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
Obstructive sleep apnea (OSA) is currently viewed as a chronic, multisystem condition associated with an increased risk of cognitive impairment, especially mild cognitive impairment (MCI). As biomarkers of neurodegeneration, we evaluated whether neurofilament light (NfL), amyloid‐β 42(Aβ‐42) and amyloid‐β 40 (Aβ‐40) can be used to indicate MCI in OSA.
Design
A cross‐sectional study.
Setting
Single‐centre trial at tertiary medical institutions.
Participants
A total of 153 newly diagnosed subjects with OSA. Main Outcomes Measures All participants completed polysomnography, neuropsychological assessments, and plasma biomarkers of neurodegeneration detection, including NfL, Aβ‐42 and Aβ‐40.
Results
Compared to the cognitively normal group, only the levels of plasma NfL were increased in the MCI group. The plasma NfL levels were associated with an increased risk of cognitive impairment in OSA patients after adjusting for age, gender, body mass index, and education year. Plasma NfL outperformed other biomarkers in differentiating MCI from normal cognition (area under the ROC curve [AUC] = 0.829). Plasma NfL, in combination with conventional factors (age, body mass index, smoking, alcohol consumption, diabetes mellitus, hypertension, history of snoring, history of apneic episodes and time ratio of SaO 2 < 90%) yielded an AUC of 0.907 for differentiating between MCI and normal cognition.
Conclusions
These findings indicate that the plasma NfL was increased in OSA patients with cognitive impairment. Furthermore, plasma NfL appears to be superior to plasma Aβ for identifying MCI in OSA and holds potential as an objective biomarker associated with MCI in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Otorhinolaryngology Head and Neck Surgery, Xi'an Children's Hospital, Xi'an, China.
- Shaanxi Provincial Key Laboratory for Precision Diagnosis and Treatment of Otorhinolaryngology, Xi'an, China.
- Department of Otorhinolaryngology, Xi'an 3rd Hospital, the Affiliated Hospital of Northwest University, Xi'an, China.
ORCID-Profile: Haiqin Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ma, L., Liu, N., Feng, Y., Zhu, S., Zhou, Y., Niu, X., Chen, X., Yuan, Y., Su, Y., Xie, Y., Shi, Y., Ren, X., & Liu, H. (2026). Exploration of Plasma Biomarkers of Neurodegeneration in Obstructive Sleep Apnea—Related Mild Cognitive Impairment. Clinical Otolaryngology. https://doi.org/10.1111/coa.70035
Vancouver
Ma L, Liu N, Feng Y, Zhu S, Zhou Y, Niu X, et al. Exploration of Plasma Biomarkers of Neurodegeneration in Obstructive Sleep Apnea—Related Mild Cognitive Impairment. Clinical Otolaryngology. 2026. doi:10.1111/coa.70035
BibTeX
@article{Ma2026,
author = {Ma, Lina and Liu, Na and Feng, Yani and Zhu, Simin and Zhou, Yanuo and Niu, Xiaoxin and Chen, Xi and Yuan, Yuqi and Su, Yonglong and Xie, Yushan and Shi, Yewen and Ren, Xiaoyong and Liu, Haiqin},
title = {Exploration of Plasma Biomarkers of Neurodegeneration in Obstructive Sleep Apnea—Related Mild Cognitive Impairment},
journal = {Clinical Otolaryngology},
year = {2026},
doi = {10.1111/coa.70035}
}
EUVIMED